Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The norgestrel-T-IUD

S El-Mahgoub

    Contraception
    |September 1, 1980
    PubMed
    Summary
    This summary is machine-generated.

    A new Norgestrel-T contraceptive device significantly reduces menstrual blood loss and termination risks. This long-acting hormonal IUD offers effective fertility control with improved user experience.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Pelvic schistosomiasis and infertility.

    International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics·1982
    Same author

    A positive proof for the theory of coelomic metaplasia.

    American journal of obstetrics and gynecology·1980
    Same author

    Body weight and cycle control of injectable contraceptives.

    The Journal of reproductive medicine·1980
    Same author

    Unification of a septate uterus: Mahgoub's operation.

    International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics·1978
    Same author

    Galactorrhea and the defective luteal phase of the menstrual cycle.

    International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics·1978
    Same author

    Laboratory and clinical experience with clotrimazole (Bay b 5097).

    Sabouraudia·1972

    Area of Science:

    • Reproductive Medicine
    • Contraception Technology
    • Gynecology

    Background:

    • Long-acting reversible contraceptives (LARCs) are crucial for effective fertility control.
    • Hormonal intrauterine devices (IUDs) offer an alternative to copper IUDs, with varying levonorgestrel release profiles.
    • Assessing endometrial effects and clinical performance of novel hormonal IUDs is essential.

    Purpose of the Study:

    • To evaluate the clinical performance of an improved long-acting Norgestrel-T (Ng-T) contraceptive device.
    • To assess the effects of different levonorgestrel release levels on the endometrium.
    • To compare the efficacy and side effect profile of the Ng-T device against the Cu-T 200.

    Main Methods:

    • A randomized comparative study involving 200 fertile women over 15 months.

    Related Experiment Videos

  • Clinical performance evaluation of Cu-T 200 and Ng-T devices.
  • Quantitation of menstrual blood loss in a subset of 20 users.

    • Main Results:

    • The Norgestrel-T (Ng-T) device demonstrated high effectiveness in fertility control.
    • A significant reduction in menstrual blood loss was observed in Ng-T users.
    • The incidence of termination due to bleeding and pain was significantly lower with the Ng-T device.

    Conclusions:

    • The improved Norgestrel-T (Ng-T) device is a highly effective contraceptive option.
    • It offers significant benefits by reducing menstrual blood loss and associated termination reasons.
    • This hormonal IUD represents an advancement in long-acting contraceptive technology.